Hematologist-oncologist and author Vinay Prasad, MD, MPH, dismantles claims that ivermectin and fenbendazole are miracle cancer cures, while also criticizing the FDA’s approval process for expensive anti-cancer drugs…
Jimmy Ruiz, MD, reflects on his career journey in North Carolina and the transformative progress in lung cancer treatment. Early in his career, limited tools like chemotherapy presented…
NEW YORK (Reuters Health) – Overall, women who were treated for cancer during childhood are about 20% less likely to become pregnant than their unaffected sisters, according to…
NEW YORK (Reuters Health) – Stereotactic body radiation therapy (SBRT) for early-stage non-small-cell lung cancer (NSCLC) results in “excellent 3-year local control and survival rates,” researchers report based…
NEW YORK (Reuters Health) – Although folate fortification of foods may reduce the rate of neural tube defects in target populations, new research from Chile suggests that it…
NEW YORK (Reuters Health) – New research suggests that marijuana use may increase the risk of testicular germ cell tumors (TGCTs), primarily nonseminoma types. According to the report…
NEW YORK (Reuters Health) – Women with synchronous primary ovarian and endometrial cancers have better survival rates than women with single ovarian cancers do, according to a report…
NEW YORK (Reuters Health) – Use of a high cut-off dialyzer can help patients with acute renal failure secondary to multiple myeloma become dialysis free, the results of…
NEW YORK (Reuters Health) For patients with epidermal growth factor (EGF) receptor-positive colorectal cancer and unresectable metastases, adding cetuximab to first-line treatment with irinotecan, fluorouracil, and leucovorin (FOLFIRI)…
NEW YORK (Reuters Health) – Annual ovarian cancer screening with transvaginal ultrasonography and CA 125 usually misses early-stage disease while it often results in unneeded surgeries, according to…
NEW YORK (Reuters Health) – For carefully selected patients with stage II to IVa laryngeal cancer, platinum-based chemotherapy may be sufficient to provide pathological complete response, results of…
NEW YORK (Reuters Health) – Consolidation therapy with low-dose thalidomide and prednisolone can improve survival in patients with multiple myeloma who have undergone autologous stem-cell transplantation (ASCT), according…
